ClariVest Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.32K | Buy |
|
|||||
|
2023
Q4 | $2.31K | Sell |
|
|||||
|
2023
Q3 | $13.1M | Sell |
|
|||||
|
2023
Q2 | $15.4M | Sell |
|
|||||
|
2023
Q1 | $19.8M | Sell |
|
|||||
|
2022
Q4 | $21.4M | Sell |
|
|||||
|
2022
Q3 | $21.7M | Sell |
|
|||||
|
2022
Q2 | $24.9M | Sell |
|
|||||
|
2022
Q1 | $24.7M | Buy |
|
|||||
|
2021
Q4 | $20.3M | Sell |
|
|||||
|
2021
Q3 | $19.8M | Sell |
|
|||||
|
2021
Q2 | $22.9M | Sell |
|
|||||
|
2021
Q1 | $22.8M | Sell |
|
|||||
|
2020
Q4 | $24.8M | Sell |
|
|||||
|
2020
Q3 | $27.9M | Sell |
|
|||||
|
2020
Q2 | $35.3M | Sell |
|
|||||
|
2020
Q1 | $40.3M | Buy |
|
|||||
|
2019
Q4 | $27.5M | Buy |
|